the purchase consideration , paid via cash , for the acquisition of the remaining 49 % interest was $ 2,300,000 plus 49 % of arapahoe 's working capital as at march 31 , 2019. additionally , the company also incurred deferred acquisition costs of $ 26,086 . 42 appointment of new ceo – april 2019 on april 9 , 2019 , the company announced the appointment of dr. tushar ramani as ceo of the company , replacing outgoing ceo edward wright . dr. ramani , a 30-year veteran of the anesthesia industry , has also joined the company 's board as a director . dr. ramani brings with him extensive experience in both managing and providing healthcare services , growing companies and creating shareholder value . south metro anesthesia associates llc ( “ smaa ” ) – may 2019 on may 16 , 2019 , a subsidiary of the company entered into an asset contribution and exchange agreement to acquire a 55 % interest in south metro anesthesia associates llc ( “ smaa ” ) , a gastroenterology anesthesia services provider in georgia . the purchase consideration , paid via cash , for the acquisition of the company 's 55 % interest was $ 1,752,465. the allocated cost of the exclusive professional service agreement which was acquired as part of this acquisition was $ 3,257,147. crystal river anesthesia associates llc ( “ craa ” ) – july 2019 on july 22 , 2019 , a subsidiary of the company entered into an asset contribution and exchange agreement to acquire a 51 % interest in crystal river anesthesia associates llc ( “ craa ” ) , a gastroenterology anesthesia services provider in florida . the purchase consideration , paid via cash , for the acquisition of the company 's 51 % interest was $ 2,130,000. the provisional allocated cost of the exclusive professional service agreement which was acquired as part of this acquisition is $ 4,262,751. central colorado anesthesia associates llc ( “ ccaa ” ) – august 2019 on august 31 , 2019 , a subsidiary of the company entered into a membership interest purchase agreement to purchase the remaining 49 % interest in central colorado anesthesia associates llc not held by the company . the purchase consideration , paid via cash , for the acquisition of the remaining 49 % interest was $ 7,000,000 plus 49 % of ccaa 's working capital as at august 31 , 2019. additionally , the company also incurred deferred acquisition costs of $ 18,658. j.p. morgan facility – october 2019 on october 22 , 2019 , the company entered into a new , three year revolving credit line which provides up to $ 200 million in borrowing capacity and represents an increase from the company 's previous $ 100 million facility . the new facility includes a committed $ 125 million facility and access to an accordion feature that increases the amount of the credit available to the company by $ 75 million . interest on the facility is calculated with reference to libor plus 1.25 % to 1.75 % , dependent on the company 's total leverage ratio . the lending syndicate for the new facility is led by jpmorgan chase bank , n.a . ( “ j.p . morgan ” ) and also includes the bank of nova scotia , u.s. bank and wells fargo . normal course issuer bid renewal – november 2019 on november 6 , 2019 , the company received approval from the toronto stock exchange ( “ tsx ” ) of its intention to renew its existing normal course issuer bid . pursuant to the bid , the company may purchase for cancellation up to 6,974,495 of its common shares , or approximately 9.8 % of the common shares outstanding as of october 31 , 2019. purchases under the bid are subject to a daily restriction of 14,875 shares . as of december 31 , 2019 , the company has repurchased 1,607,579 common shares under both its previous and current normal course issuer bids for a total of $ 4,754,295 ( cad $ 6,313,347 ) , including transaction fees . triad sedation associates llc & triad support services llc ( collectively “ tsa ” ) – november 2019 effective november 1 , 2019 , the company entered into a membership interest purchase agreement to purchase an additional 36 % interest in tsa , taking its ownership interest from 15 % to 51 % . the purchase consideration , paid via cash , for the additional 36 % interest was $ 3,185,843 plus deferred consideration of $ 627,645 and deferred acquisition costs of $ 15,173. upon completing the transaction crh acquired control of tsa ; the company has consolidated the results of tsa from the date control was obtained , november 1 , 2019. on conversion from an equity method investment to consolidation , crh revalued its investment in tsa , resulting in a gain of $ 1,318,769. the provisional allocated cost of the exclusive professional service agreement which was acquired as part of this acquisition is $ 8,891,711 . 43 f lorida panhandle anest hesia associates llc ( “ fpaa ” ) – december 2019 on december 17 , 2019 , a subsidiary of the company entered into an asset contribution and exchange agreement to acquire a 51 % interest in florida panhandle anesthesia associates llc ( “ fpaa ” ) , a gastroenterology anesthesia services provider in florida . the purchase consideration , paid via cash , for the acquisition of the company 's 51 % interest was $ 2,725,000. the provisional allocated cost of the exclusive professional service agreement which was acquired as part of this acquisition is $ 5,416,278. results of operations the following tables provide a detailed analysis of our results of operations and financial condition . story_separator_special_tag adjusted operating ebitda attributable to non-controlling interest was $ 15,080,425 for the year ended december 31 , 2019. this comprises the non-controlling interests ' share of revenues of $ 29,808,084 and adjusted operating expenses of $ 14,727,659 and is a decrease of $ 3,775,773. similar to adjusted operating ebitda attributable to shareholders , the decrease is a reflection of the decrease in revenue rates in the period for commercial payors . adjusted operating ebitda attributable to non-controlling interest was $ 3,465,297 for the three months ended december 31 , 2019. this comprises the non-controlling interests ' share of revenues of $ 7,292,235 and adjusted operating expenses of $ 3,826,938. total adjusted operating ebitda was $ 51,703,649 for the year ended december 31 , 2019 , a decrease of 5 % from the same period in 2018. total adjusted operating ebitda was $ 12,270,038 for the three months ended december 31 , 2019 , a decrease of 23 % from the same period in 2018. net finance ( income ) / expense as a result of the company 's debt facilities and long-term finance obligations , the company has recorded a net finance expense of $ 6,609,618 for the year ended december 31 , 2019 , compared to a net finance expense of $ 4,567,327 for the year ended december 31 , 2018. net finance expense is comprised of both interest and other debt related expenses , including fair value adjustments . fair value adjustments related to the company 's earn-out obligation are the primary driver of significant fluctuations in finance expense between comparable periods . 1 see `` use of non-gaap financial measures `` below for definitions of non-gaap-based measures and reconciliations of gaap-based measures to non-gaap-based measures . 49 replace_table_token_11_th during the year ended december 31 , 2019 , the company recognized a fair value adjustment of $ 2,861,204 in respect of its earn-out obligation . the fair value adjustment resulted from changes in estimates underlying the company 's earn-out obligation . the changes in estimates underlying the company 's earn-out obligation were driven primarily by the changes in the cash flow estimates , which were driven by both changes in payor mix and revenue rates per unit . during the three months ended december 31 , 2019 , the company recognized a fair value adjustment of $ 89,966 in respect of its earn-out obligation . cash interest paid in the year ended december 31 , 2019 was $ 3,055,374 compared to $ 3,180,808 cash interest paid in 2018. as at december 31 , 2019 , the company owed $ 69.3 million under its jp morgan facility as compared to $ 70.25 million owed at december 31 , 2018 under its facility with the bank of nova scotia . the company anticipates that , in future , cash interest will fluctuate as the company draws or repays on its facility and as libor rates fluctuate . income tax expense for the year ended december 31 , 2019 , the company recorded an income tax expense of $ 1,627,061 compared to income tax expense of $ 2,711,886 for the year ended december 31 , 2018. income tax expense relates only to income attributable to the company 's shareholders . the company recorded an income tax expense of $ 891,009 in the three months ended december 31 , 2019 compared to $ 1,059,442 recorded in the three months ended december 31 , 2018. the decrease in tax expense period over period is a reflection of the decrease in taxable income in the period . net and comprehensive income for the year ended december 31 , 2019 , the company recorded net and comprehensive income attributable to shareholders of the company of $ 3,771,163 compared to net and comprehensive income attributable to shareholders of $ 4,679,921 for the year ended december 31 , 2018. the decrease year over year is largely a reflection of the decrease in operating income in the period , offset by income and gains earned on its tsa equity investment . for the three months ended december 31 , 2019 , the company recorded net and comprehensive income attributable to shareholders of the company of $ 1,219,079 compared to $ 1,711,144 for the same period in 2018. the decrease period over period is largely a reflection of the decrease in operating income in the period offset by gains earned on its tsa equity investment . net and comprehensive income attributable to non-controlling interest was $ 4,441,321 for the year ended december 31 , 2019 compared to $ 8,335,996. this reflects the business model adopted by crh whereby recent acquisitions , though controlled by crh , attribute a portion of income earned to non-controlling interests . net and comprehensive income attributable to non-controlling interests was $ 884,610 for the three months ended december 31 , 2019 compared to $ 2,437,108 for the three months ended december 31 , 2018. during the year , crh acquired the remaining non-controlling interest in ccaa and arapahoe , reducing net income attributable to non-controlling interest when compared to prior periods . additionally , the decrease in net and comprehensive income attributable to non-controlling interest is reflective of the decrease in adjusted operating ebitda in the period . 50 use of non-gaap financial measures as discussed above , in addition to results reported in accordance with us gaap , the company uses certain non-gaap financial measures , including adjusted operating expenses ( in total and broken down by operating segment ) , adjusted operating ebitda ( in total and broken down as attributable to non-controlling interest and shareholders of the company ) , and adjusted operating ebitda margin as supplemental indicators of its financial and operating performance . these non-gaap measures are not recognized measures under us gaap and do not have a standardized meaning prescribed by u.s. generally accepted accounting principles ( “ us gaap ” ) and thus the company 's definition may be different from and unlikely to be comparable to

liquidity and capital resources at december 31 , 2019 , the company had $ 6,568,716 in cash and cash equivalents compared to $ 9,946,945 at the end of 2018. the decrease in cash and equivalents is primarily a reflection of cash generated from operations and debt financing activities , less cash used to finance normal course issuer bid repurchases and acquisitions during 2019 , less repayment of debt in the period . working capital was $ 18,677,498 at december 31 , 2019 compared to working capital of $ 20,012,424 at december 31 , 2018. the company expects to meet its short-term obligations , including short-term obligations in respect of its notes payable and deferred consideration through cash earned through operating activities . the average number of days receivables outstanding at december 31 , 2019 was 59 days . at december 31 , 2018 , the average number of days receivables outstanding was 54 days . the company continues to monitor this measure on an ongoing basis . 53 the company has financed its operations primarily from revenues generated fr om product sales and anesthesia services and through equity and debt financings and a revolving credit facility . as of december 31 , 201 9 , the company has raised approximately $ 51 million from the sale and issuance of equity securities . the company also obt ained debt financing of $ 52 million via senior and subordinated credit facilities in 2014 and entered into a revolving credit facility with the bank of nova scotia for $ 33 million in 2015 , which was subsequently increased to $ 55 million in 2016 and $ 100 mi llion in 2017. most recently , the company entered into a syndicated debt facility with jp morgan chase bank , increasing its facility to $ 200 million on october 22 , 2019. as at december 31 , 2019 , the company owed $ 69.3 million under the facility . the terms of the company 's facility as of december 31 , 2019 is described below .


 Write a concise suspicious activity report of the following text delimited by triple backquotes. Return your response as a formal report which covers the key points highlighting the location,dates,entity names and account holder information in chronological order of the text.
     ```liquidity and capital resources at december 31 , 2019 , the company had $ 6,568,716 in cash and cash equivalents compared to $ 9,946,945 at the end of 2018. the decrease in cash and equivalents is primarily a reflection of cash generated from operations and debt financing activities , less cash used to finance normal course issuer bid repurchases and acquisitions during 2019 , less repayment of debt in the period . working capital was $ 18,677,498 at december 31 , 2019 compared to working capital of $ 20,012,424 at december 31 , 2018. the company expects to meet its short-term obligations , including short-term obligations in respect of its notes payable and deferred consideration through cash earned through operating activities . the average number of days receivables outstanding at december 31 , 2019 was 59 days . at december 31 , 2018 , the average number of days receivables outstanding was 54 days . the company continues to monitor this measure on an ongoing basis . 53 the company has financed its operations primarily from revenues generated fr om product sales and anesthesia services and through equity and debt financings and a revolving credit facility . as of december 31 , 201 9 , the company has raised approximately $ 51 million from the sale and issuance of equity securities . the company also obt ained debt financing of $ 52 million via senior and subordinated credit facilities in 2014 and entered into a revolving credit facility with the bank of nova scotia for $ 33 million in 2015 , which was subsequently increased to $ 55 million in 2016 and $ 100 mi llion in 2017. most recently , the company entered into a syndicated debt facility with jp morgan chase bank , increasing its facility to $ 200 million on october 22 , 2019. as at december 31 , 2019 , the company owed $ 69.3 million under the facility . the terms of the company 's facility as of december 31 , 2019 is described below .
```    
 Suspicious Activity Report : the purchase consideration , paid via cash , for the acquisition of the remaining 49 % interest was $ 2,300,000 plus 49 % of arapahoe 's working capital as at march 31 , 2019. additionally , the company also incurred deferred acquisition costs of $ 26,086 . 42 appointment of new ceo – april 2019 on april 9 , 2019 , the company announced the appointment of dr. tushar ramani as ceo of the company , replacing outgoing ceo edward wright . dr. ramani , a 30-year veteran of the anesthesia industry , has also joined the company 's board as a director . dr. ramani brings with him extensive experience in both managing and providing healthcare services , growing companies and creating shareholder value . south metro anesthesia associates llc ( “ smaa ” ) – may 2019 on may 16 , 2019 , a subsidiary of the company entered into an asset contribution and exchange agreement to acquire a 55 % interest in south metro anesthesia associates llc ( “ smaa ” ) , a gastroenterology anesthesia services provider in georgia . the purchase consideration , paid via cash , for the acquisition of the company 's 55 % interest was $ 1,752,465. the allocated cost of the exclusive professional service agreement which was acquired as part of this acquisition was $ 3,257,147. crystal river anesthesia associates llc ( “ craa ” ) – july 2019 on july 22 , 2019 , a subsidiary of the company entered into an asset contribution and exchange agreement to acquire a 51 % interest in crystal river anesthesia associates llc ( “ craa ” ) , a gastroenterology anesthesia services provider in florida . the purchase consideration , paid via cash , for the acquisition of the company 's 51 % interest was $ 2,130,000. the provisional allocated cost of the exclusive professional service agreement which was acquired as part of this acquisition is $ 4,262,751. central colorado anesthesia associates llc ( “ ccaa ” ) – august 2019 on august 31 , 2019 , a subsidiary of the company entered into a membership interest purchase agreement to purchase the remaining 49 % interest in central colorado anesthesia associates llc not held by the company . the purchase consideration , paid via cash , for the acquisition of the remaining 49 % interest was $ 7,000,000 plus 49 % of ccaa 's working capital as at august 31 , 2019. additionally , the company also incurred deferred acquisition costs of $ 18,658. j.p. morgan facility – october 2019 on october 22 , 2019 , the company entered into a new , three year revolving credit line which provides up to $ 200 million in borrowing capacity and represents an increase from the company 's previous $ 100 million facility . the new facility includes a committed $ 125 million facility and access to an accordion feature that increases the amount of the credit available to the company by $ 75 million . interest on the facility is calculated with reference to libor plus 1.25 % to 1.75 % , dependent on the company 's total leverage ratio . the lending syndicate for the new facility is led by jpmorgan chase bank , n.a . ( “ j.p . morgan ” ) and also includes the bank of nova scotia , u.s. bank and wells fargo . normal course issuer bid renewal – november 2019 on november 6 , 2019 , the company received approval from the toronto stock exchange ( “ tsx ” ) of its intention to renew its existing normal course issuer bid . pursuant to the bid , the company may purchase for cancellation up to 6,974,495 of its common shares , or approximately 9.8 % of the common shares outstanding as of october 31 , 2019. purchases under the bid are subject to a daily restriction of 14,875 shares . as of december 31 , 2019 , the company has repurchased 1,607,579 common shares under both its previous and current normal course issuer bids for a total of $ 4,754,295 ( cad $ 6,313,347 ) , including transaction fees . triad sedation associates llc & triad support services llc ( collectively “ tsa ” ) – november 2019 effective november 1 , 2019 , the company entered into a membership interest purchase agreement to purchase an additional 36 % interest in tsa , taking its ownership interest from 15 % to 51 % . the purchase consideration , paid via cash , for the additional 36 % interest was $ 3,185,843 plus deferred consideration of $ 627,645 and deferred acquisition costs of $ 15,173. upon completing the transaction crh acquired control of tsa ; the company has consolidated the results of tsa from the date control was obtained , november 1 , 2019. on conversion from an equity method investment to consolidation , crh revalued its investment in tsa , resulting in a gain of $ 1,318,769. the provisional allocated cost of the exclusive professional service agreement which was acquired as part of this acquisition is $ 8,891,711 . 43 f lorida panhandle anest hesia associates llc ( “ fpaa ” ) – december 2019 on december 17 , 2019 , a subsidiary of the company entered into an asset contribution and exchange agreement to acquire a 51 % interest in florida panhandle anesthesia associates llc ( “ fpaa ” ) , a gastroenterology anesthesia services provider in florida . the purchase consideration , paid via cash , for the acquisition of the company 's 51 % interest was $ 2,725,000. the provisional allocated cost of the exclusive professional service agreement which was acquired as part of this acquisition is $ 5,416,278. results of operations the following tables provide a detailed analysis of our results of operations and financial condition . story_separator_special_tag adjusted operating ebitda attributable to non-controlling interest was $ 15,080,425 for the year ended december 31 , 2019. this comprises the non-controlling interests ' share of revenues of $ 29,808,084 and adjusted operating expenses of $ 14,727,659 and is a decrease of $ 3,775,773. similar to adjusted operating ebitda attributable to shareholders , the decrease is a reflection of the decrease in revenue rates in the period for commercial payors . adjusted operating ebitda attributable to non-controlling interest was $ 3,465,297 for the three months ended december 31 , 2019. this comprises the non-controlling interests ' share of revenues of $ 7,292,235 and adjusted operating expenses of $ 3,826,938. total adjusted operating ebitda was $ 51,703,649 for the year ended december 31 , 2019 , a decrease of 5 % from the same period in 2018. total adjusted operating ebitda was $ 12,270,038 for the three months ended december 31 , 2019 , a decrease of 23 % from the same period in 2018. net finance ( income ) / expense as a result of the company 's debt facilities and long-term finance obligations , the company has recorded a net finance expense of $ 6,609,618 for the year ended december 31 , 2019 , compared to a net finance expense of $ 4,567,327 for the year ended december 31 , 2018. net finance expense is comprised of both interest and other debt related expenses , including fair value adjustments . fair value adjustments related to the company 's earn-out obligation are the primary driver of significant fluctuations in finance expense between comparable periods . 1 see `` use of non-gaap financial measures `` below for definitions of non-gaap-based measures and reconciliations of gaap-based measures to non-gaap-based measures . 49 replace_table_token_11_th during the year ended december 31 , 2019 , the company recognized a fair value adjustment of $ 2,861,204 in respect of its earn-out obligation . the fair value adjustment resulted from changes in estimates underlying the company 's earn-out obligation . the changes in estimates underlying the company 's earn-out obligation were driven primarily by the changes in the cash flow estimates , which were driven by both changes in payor mix and revenue rates per unit . during the three months ended december 31 , 2019 , the company recognized a fair value adjustment of $ 89,966 in respect of its earn-out obligation . cash interest paid in the year ended december 31 , 2019 was $ 3,055,374 compared to $ 3,180,808 cash interest paid in 2018. as at december 31 , 2019 , the company owed $ 69.3 million under its jp morgan facility as compared to $ 70.25 million owed at december 31 , 2018 under its facility with the bank of nova scotia . the company anticipates that , in future , cash interest will fluctuate as the company draws or repays on its facility and as libor rates fluctuate . income tax expense for the year ended december 31 , 2019 , the company recorded an income tax expense of $ 1,627,061 compared to income tax expense of $ 2,711,886 for the year ended december 31 , 2018. income tax expense relates only to income attributable to the company 's shareholders . the company recorded an income tax expense of $ 891,009 in the three months ended december 31 , 2019 compared to $ 1,059,442 recorded in the three months ended december 31 , 2018. the decrease in tax expense period over period is a reflection of the decrease in taxable income in the period . net and comprehensive income for the year ended december 31 , 2019 , the company recorded net and comprehensive income attributable to shareholders of the company of $ 3,771,163 compared to net and comprehensive income attributable to shareholders of $ 4,679,921 for the year ended december 31 , 2018. the decrease year over year is largely a reflection of the decrease in operating income in the period , offset by income and gains earned on its tsa equity investment . for the three months ended december 31 , 2019 , the company recorded net and comprehensive income attributable to shareholders of the company of $ 1,219,079 compared to $ 1,711,144 for the same period in 2018. the decrease period over period is largely a reflection of the decrease in operating income in the period offset by gains earned on its tsa equity investment . net and comprehensive income attributable to non-controlling interest was $ 4,441,321 for the year ended december 31 , 2019 compared to $ 8,335,996. this reflects the business model adopted by crh whereby recent acquisitions , though controlled by crh , attribute a portion of income earned to non-controlling interests . net and comprehensive income attributable to non-controlling interests was $ 884,610 for the three months ended december 31 , 2019 compared to $ 2,437,108 for the three months ended december 31 , 2018. during the year , crh acquired the remaining non-controlling interest in ccaa and arapahoe , reducing net income attributable to non-controlling interest when compared to prior periods . additionally , the decrease in net and comprehensive income attributable to non-controlling interest is reflective of the decrease in adjusted operating ebitda in the period . 50 use of non-gaap financial measures as discussed above , in addition to results reported in accordance with us gaap , the company uses certain non-gaap financial measures , including adjusted operating expenses ( in total and broken down by operating segment ) , adjusted operating ebitda ( in total and broken down as attributable to non-controlling interest and shareholders of the company ) , and adjusted operating ebitda margin as supplemental indicators of its financial and operating performance . these non-gaap measures are not recognized measures under us gaap and do not have a standardized meaning prescribed by u.s. generally accepted accounting principles ( “ us gaap ” ) and thus the company 's definition may be different from and unlikely to be comparable to

